Literature DB >> 16894609

Endogenous bone morphogenetic protein antagonists regulate mammalian neural crest generation and survival.

Ryan M Anderson1, Rolf W Stottmann, Murim Choi, John Klingensmith.   

Abstract

We demonstrate here that Chordin and Noggin function as bone morphogenetic protein (BMP) antagonists in vivo to promote mammalian neural crest development. Using Chrd and Nog single and compound mutants, we find that Noggin has a major role in promoting neural crest formation, in which Chordin is partially redundant. BMP signaling is increased in dorsal tissues lacking Noggin and is further increased when Chordin is also absent. The early neural crest domain is expanded with decreased BMP antagonism in vivo. Noggin and Chordin also regulate subsequent neural crest cell emigration from the neural tube. However, reduced levels of these BMP antagonists ultimately result in perturbation of neural crest cell derived peripheral nervous system and craniofacial skeletal elements. Such defects reflect, at least in part, a function to limit apoptosis in neural crest cells. Noggin and Chordin, therefore, function together to regulate both the generation and survival of neural crest cells in mammalian development. Copyright 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16894609      PMCID: PMC6626635          DOI: 10.1002/dvdy.20891

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  33 in total

1.  Trigenic neural crest-restricted Smad7 over-expression results in congenital craniofacial and cardiovascular defects.

Authors:  Sunyong Tang; Paige Snider; Antony B Firulli; Simon J Conway
Journal:  Dev Biol       Date:  2010-05-08       Impact factor: 3.582

Review 2.  Cranial neural crest cells on the move: their roles in craniofacial development.

Authors:  Dwight R Cordero; Samantha Brugmann; Yvonne Chu; Ruchi Bajpai; Maryam Jame; Jill A Helms
Journal:  Am J Med Genet A       Date:  2010-12-10       Impact factor: 2.802

3.  Diversity in the molecular and cellular strategies of epithelium-to-mesenchyme transitions: Insights from the neural crest.

Authors:  Jean-Loup Duband
Journal:  Cell Adh Migr       Date:  2010-07-27       Impact factor: 3.405

4.  Noggin is required for early development of murine upper incisors.

Authors:  X Hu; Y Wang; F He; L Li; Y Zheng; Y Zhang; Y P Chen
Journal:  J Dent Res       Date:  2012-02-02       Impact factor: 6.116

5.  Tissue interaction is required for glenoid fossa development during temporomandibular joint formation.

Authors:  Ying Wang; Chao Liu; Joseph Rohr; Hongbing Liu; Fenglei He; Jian Yu; Cheng Sun; Lu Li; Shuping Gu; YiPing Chen
Journal:  Dev Dyn       Date:  2011-09-26       Impact factor: 3.780

6.  Modulation of BMP signaling by Noggin is required for the maintenance of palatal epithelial integrity during palatogenesis.

Authors:  Fenglei He; Wei Xiong; Ying Wang; Maiko Matsui; Xueyan Yu; Yang Chai; John Klingensmith; Yiping Chen
Journal:  Dev Biol       Date:  2010-08-19       Impact factor: 3.582

7.  Sensory nerve induced inflammation contributes to heterotopic ossification.

Authors:  Elizabeth Salisbury; Eric Rodenberg; Corinne Sonnet; John Hipp; Francis H Gannon; Tegy J Vadakkan; Mary E Dickinson; Elizabeth A Olmsted-Davis; Alan R Davis
Journal:  J Cell Biochem       Date:  2011-10       Impact factor: 4.429

8.  Geminin is required for epithelial to mesenchymal transition at gastrulation.

Authors:  Lisa S D Emmett; K Sue O'Shea
Journal:  Stem Cells Dev       Date:  2012-04-16       Impact factor: 3.272

9.  Strain-specific modifier genes governing craniofacial phenotypes.

Authors:  Partha Mukhopadhyay; Guy Brock; Cynthia Webb; M Michele Pisano; Robert M Greene
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2012-02-28

10.  A critical role of noggin in developing folate-nonresponsive NTD in Fkbp8 -/- embryos.

Authors:  Takao Tsurubuchi; Elise V Allender; M Rizwan Siddiqui; Kyu-Won Shim; Shunsuke Ichi; Vanda Boshnjaku; Barbara Mania-Farnell; Guifa Xi; Richard H Finnell; David G McLone; Tadanori Tomita; C S Mayanil
Journal:  Childs Nerv Syst       Date:  2014-05-10       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.